BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28771630)

  • 21. Synaptic plasticity in the dy2J mouse model of laminin alpha2-deficient congenital muscular dystrophy.
    Anderson JL; Head SI; Morley JW
    Brain Res; 2005 Apr; 1042(1):23-8. PubMed ID: 15823249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
    Gawlik KI; Holmberg J; Durbeej M
    Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics.
    Barraza-Flores P; Bates CR; Oliveira-Santos A; Burkin DJ
    Front Mol Neurosci; 2020; 13():1. PubMed ID: 32116540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K/dy3K) mice.
    Nakagawa M; Miyagoe-Suzuki Y; Ikezoe K; Miyata Y; Nonaka I; Harii K; Takeda S
    Glia; 2001 Aug; 35(2):101-10. PubMed ID: 11460266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.
    Vilquin JT; Kinoshita I; Roy B; Goulet M; Engvall E; Tomé F; Fardeau M; Tremblay JP
    J Cell Biol; 1996 Apr; 133(1):185-97. PubMed ID: 8601607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy.
    Willmann R; Gordish-Dressman H; Meinen S; Rüegg MA; Yu Q; Nagaraju K; Kumar A; Girgenrath M; Coffey CBM; Cruz V; Van Ry PM; Bogdanik L; Lutz C; Rutkowski A; Burkin DJ
    J Neuromuscul Dis; 2017; 4(2):115-126. PubMed ID: 28550268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
    Moll J; Barzaghi P; Lin S; Bezakova G; Lochmüller H; Engvall E; Müller U; Ruegg MA
    Nature; 2001 Sep; 413(6853):302-7. PubMed ID: 11565031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice.
    Sunada Y; Bernier SM; Utani A; Yamada Y; Campbell KP
    Hum Mol Genet; 1995 Jun; 4(6):1055-61. PubMed ID: 7655459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.
    Gawlik KI; Holmberg J; Svensson M; Einerborg M; Oliveira BM; Deierborg T; Durbeej M
    Sci Rep; 2017 Mar; 7():44059. PubMed ID: 28281577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.
    Girgenrath M; Dominov JA; Kostek CA; Miller JB
    J Clin Invest; 2004 Dec; 114(11):1635-9. PubMed ID: 15578095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Merosin and congenital muscular dystrophy.
    Miyagoe-Suzuki Y; Nakagawa M; Takeda S
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired Regeneration in Dystrophic Muscle-New Target for Therapy.
    Yanay N; Rabie M; Nevo Y
    Front Mol Neurosci; 2020; 13():69. PubMed ID: 32523512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].
    Smeyers P
    Rev Neurol; 1999 Jan 16-31; 28(2):141-9. PubMed ID: 10101782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early skeletal muscle pathology and disease progress in the dy
    Gawlik KI; Körner Z; Oliveira BM; Durbeej M
    Sci Rep; 2019 Oct; 9(1):14324. PubMed ID: 31586140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-αLN linker protein.
    McKee KK; Yurchenco PD
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35639486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.
    Xu H; Wu XR; Wewer UM; Engvall E
    Nat Genet; 1994 Nov; 8(3):297-302. PubMed ID: 7874173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
    Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructure of muscle spindles in C57BL/6J dy2J/dy2J dystrophic mice.
    James NT; Meek GA
    Experientia; 1979 Jan; 35(1):108-9. PubMed ID: 154410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin alpha2 chain gene.
    Besse S; Allamand V; Vilquin JT; Li Z; Poirier C; Vignier N; Hori H; Guénet JL; Guicheney P
    Neuromuscul Disord; 2003 Mar; 13(3):216-22. PubMed ID: 12609503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linker proteins restore basement membrane and correct
    Reinhard JR; Lin S; McKee KK; Meinen S; Crosson SC; Sury M; Hobbs S; Maier G; Yurchenco PD; Rüegg MA
    Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.